Company Cryoport, Inc.

Equities

CYRX

US2290503075

Air Freight & Logistics

Market Closed - Nasdaq 16:00:00 2024-04-26 EDT 5-day change 1st Jan Change
16.38 USD +2.18% Intraday chart for Cryoport, Inc. +1.55% +5.75%

Business Summary

Cryoport, Inc. is engaged in supply chain solutions for cell and gene therapies. The Company’s supply chain solutions enable manufacturers, contract manufacturers (CDMO’s), contract research organizations (CRO’s), developers, and researchers to carry out their business with certainty. The Company provides a broad array of supply chain solutions for the life sciences industry. Through its platform of critical products and solutions, including advanced temperature-controlled packaging, informatics, specialized bio-logistics services, bio-storage, bio-services, and cryogenic systems, the Company is enabling the future of medicine worldwide, through its systems, compliant procedures, and approach to supply chain management. Its products and services include Cryoport Express Shippers, Cryoport ELITE Shipper Systems, Cryoport Consulting Services, Cryoport Bioservices, CRYOGENE, CRYOPDP Temperature-controlled Logistics, Cryoport Cryoshuttle, IntegriCell Services, Tec4Med, and others.

Number of employees: 1,025

Sales per Business

USD in Million2022Weight2023Weight Delta
Biopharma/Pharma
82.6 %
194 81.7 % 193 82.6 % -0.67%
Animal Health
13.0 %
33 14.1 % 30 13.0 % -9.22%
Human Reproductive Medicine
4.4 %
10 4.2 % 10 4.4 % +3.62%

Sales per region

USD in Million2022Weight2023Weight Delta
Americas
54.5 %
128 54.0 % 127 54.5 % -0.78%
Europe, Middle East and Africa
26.1 %
42 17.8 % 61 26.1 % +44.43%
Asia Pacific
19.4 %
67 28.2 % 45 19.4 % -32.51%

Managers

Managers TitleAgeSince
Chief Executive Officer 76 12-10-21
Director of Finance/CFO 59 11-06-26
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer 63 13-09-12
Investor Relations Contact - 15-09-30

Members of the board

Members of the board TitleAgeSince
Director/Board Member 81 14-12-31
Director/Board Member 63 21-03-14
Chief Executive Officer 76 12-10-21
Chief Tech/Sci/R&D Officer 63 13-09-12
Director/Board Member 65 15-09-24
Director/Board Member 59 14-06-15
Director/Board Member 45 20-09-30
Director/Board Member 72 19-01-06

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 200,000 0 0 97.54 %
Stock B 1 49,164,478 47,956,893 ( 97.54 %) 0

Shareholders

NameEquities%Valuation
Brown Capital Management LLC
13.79 %
6,754,317 13.79 % 120 M $
Morgan Stanley Investment Management, Inc.
8.517 %
4,171,535 8.517 % 74 M $
Vanguard Fiduciary Trust Co.
7.468 %
3,657,661 7.468 % 65 M $
Cadian Capital Management LP
7.073 %
3,464,079 7.073 % 61 M $
BlackRock Advisors LLC
6.860 %
3,359,694 6.860 % 59 M $
Impax Asset Management Ltd.
5.307 %
2,599,149 5.307 % 46 M $
Invesco Advisers, Inc.
4.497 %
2,202,726 4.497 % 39 M $
Massachusetts Financial Services Co.
4.069 %
1,992,895 4.069 % 35 M $
Fred Alger Management LLC (13f Subfiler)
4.062 %
1,989,396 4.062 % 35 M $
New York State Common Retirement Fund
3.354 %
1,642,752 3.354 % 29 M $
NameEquities%Valuation
Blackstone Corporate Private Equity
97.72 %
195,439 97.72 % 3 M $

Company contact information

CryoPort, Inc.

112 Westwood Place Suite 350

37027, Brentwood

+949 470 2300

http://www.cryoport.com
address Cryoport, Inc.(CYRX)

Group companies

NameCategory and Sector
Cryoport Netherlands BV
  1. Stock Market
  2. Equities
  3. CYRX Stock
  4. Company Cryoport, Inc.